Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Diagnostic Pathology
Published in: Diagnostic Pathology 1/2015

Open Access 01-12-2015 | Case Report

Rectal hodgkin lymphoma in a patient with ulcerative colitis: a case study

Authors: Simon Ladefoged Rasmussen, Christian Thomsen

Published in: Diagnostic Pathology | Issue 1/2015

Login to get access

Abstract

A case of Hodgkin lymphoma located in the rectum of a patient with ulcerative colitis is described. The patient was a 44 year old male treated with thiopurines for ulcerative colitis for ten years. He was admitted with malaise, weight loss and abdominal pain. Endoscopy revealed a large ulcerative lesion involving the rectum and distal part of the sigmoid colon. Although it macroscopically resembled a rectal cancer, repeated biopsies did not reveal any malignancy. In order to resolve the symptoms of stenosis and to get the final diagnosis a recto-sigmoid resection was performed. Pathologic examination revealed nodular sclerosis classical Hodgkin lymphoma, positive for Epstein Barr Virus. Subsequent examination revealed disseminated disease involving the pelvic wall, liver, and bone marrow. The patient is currently receiving chemotherapeutic treatment, and follow-up shows disease remission.
Hodgkin lymphoma associated with immunosuppressive therapy is rare. However, patients with ulcerative colitis receiving such treatment are at increased risk of lymphoproliferative disordes, potentially due to loss of immunosurveillance and presence of oncogenic viruses (i.e. Epstein-Barr virus).
Virtual Slides: The virtual slide(s) for this article can be found here: http://​www.​diagnosticpathol​ogy.​diagnomx.​eu/​vs/​6156776351558952​
Literature
1.
Siegel R, Ma J, Zou Z, Jemal A. Cancer Stat. 2014;2014:9–29.
2.
Wong MTC, Eu KW. Primary Colorectal Lymphomas. 2006. p. 586–91.
3.
Hall AG, Taylor R, Evans RG, Curtis M, Proctor SJ. Hodgkin’s Disease Involving the Large Bowel. 1988. p. 193–4.
4.
Zemsky L, Katz H, Edelman M, Makower D. Hodgkin’s Disease Involving the Large Bowel. 2001. p. 185–6.
5.
Thomas DB, Huston BM, Lamm KR, Maia DM. Primary Hodgkin’s Disease of the Sigmoid Colon: A Case Report and Review of the Literature. 1997. p. 528–32.
6.
Garnier JL, Lebranchu Y, Dantal J, Bedrossian J, Cahen R, Assouline D, et al. Hodgkin’s Disease after Transplantation. 1996. p. 71–6.
7.
Glaser SL, Clarke CA, Gulley ML, Craig FE, DiGiuseppe JA, Dorfman RF, et al. Population-Based Patterns of Human Immunodeficiency Virus-Related Hodgkin Lymphoma in the Greater San Francisco Bay Area, 1988–1998. 2003. p. 300–9.
8.
Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. 2012;382–9.
9.
Jess T, Horváth-Puhó E, Fallingborg J, Rasmussen HH, Jacobsen BA. Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study. 2013. p. 1869–76.
10.
Lewis JD, Bilker WB, Brensinger C, Deren JJ, Vaughn DJ, Strom BL. Inflammatory Bowel Disease is not Associated with an Increased Risk of Lymphoma. 2001. p. 1080–7.
11.
Askling J, Brandt L, Lapidus A, Karlén P, Björkholm M, Löfberg R, et al. Risk of Haematopoietic Cancer in Patients With Inflammatory Bowel Disease. 2005. p. 617–22.
12.
Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Lémann M, Cosnes J, et al. Lymphoproliferative Disorders in Patients Receiving Thiopurines for Inflammatory Bowel Disease: A Prospective Observational Cohort Study. 2009. p. 1617–25.
13.
Baecklund E, Ekbom A, Sparén P, Feltelius N, Klareskog L. Disease Activity and Risk of Lymphoma in Patients with Rheumatoid Arthritis: Nested Case–Control Study. 1998. p. 180–1.
14.
Jones JL, Loftus EV. Lymphoma Risk in Inflammatory Bowel Disease: is it The Disease or its Treatment? 2007. p. 1299–307.
15.
Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, et al. Classical Hodgkin Lymphoma Arising in The Setting of Iatrogenic Immunodeficiency: A Clinicopathologic Study of 10 Cases. 2013. p. 1290–7.
16.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition. 2008. p. 439.
Metadata
Title
Rectal hodgkin lymphoma in a patient with ulcerative colitis: a case study
Authors
Simon Ladefoged Rasmussen
Christian Thomsen
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2015
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/s13000-015-0271-7

Other articles of this Issue 1/2015

Diagnostic Pathology 1/2015 Go to the issue

Research

RETRACTED ARTICLE: Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma

Research

Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status

Research

Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia

Research

RETRACTED ARTICLE: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues

Research

Acetylcholinesterase histochemistry (AChE) - A helpful technique in the diagnosis and in aiding the operative procedures of Hirschsprung disease

Research

Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy